The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors.EBI
Aurigene Discovery Technologies
Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors.EBI
Aurigene Discovery Technologies
Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.EBI
Aurigene Discovery Technologies
Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors.EBI
Aurigene Discovery Technologies
Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: wild type and mutant (L1196M) active compounds with unique binding mode.EBI
Aurigene Discovery Technologies
Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors.EBI
Aurigene Discovery Technologies
Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action.EBI
Aurigene Discovery Technologies
Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies.EBI
Aurigene Discovery Technologies
Pyrrolo[1,2-b] pyridazine derivativesBDB
Gilead Sciences
Compounds useful as RET inhibitorsBDB
Cancer Research Technology
5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agentsBDB
Temple University
Adrenergic receptor modulating compounds and methods of using the sameBDB
The Leland Stanford Junior University
Therapeutic compounds and uses thereofBDB
Genentech
Compositions for APP-selective BACE inhibition and uses thereforBDB
University of California
Alkynyl pyridine prolyl hydroxylase inhibitor, and preparation method and medical use thereofBDB
Jiangsu Hengrui Medicine